Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/09/2005CN1694895A Modified transferrin-antibody fusion proteins
11/09/2005CN1694722A A process for the preparation of a non-toxic anthrax vaccine
11/09/2005CN1694720A Lactoferrin compositions and methods of wound treatment
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/09/2005CN1694718A Modified asialo-interferons and uses thereof
11/09/2005CN1694717A Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/09/2005CN1226412C Deactivated protein gene in ribosome of motherwort
11/09/2005CN1226305C Protein extracted from perinereis aibuhitensis, its preparation method and use
11/09/2005CN1226046C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor and pharmaceutical compositions containing same
11/08/2005US6962985 Mammalian neuralized family transcriptional regulators and uses therefor
11/08/2005US6962981 denaturing-free; for immunoassay; for diagnosis/treatment of cancer
11/08/2005US6962980 Stimulant immunology response; polynucleotides
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962977 Insecticides; microbiocides; for plants, seeds
11/08/2005US6962974 non-Goodpasture fragments/domains for binding integrins/endothelial cells, and inhibiting proliferation of tumors/endothelial cells
11/08/2005US6962972 Active material; denaturing protein; hybrid enzyme
11/08/2005US6962970 Glycopeptide derivatives and pharmaceutical compositions containing the same
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/08/2005US6962905 Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/08/2005US6962904 Elastin peptide analogs and uses thereof
11/08/2005US6962903 Modified annexin proteins and methods for preventing thrombosis
11/08/2005US6962902 Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
11/08/2005US6962900 Pharmaceutical being used for treating HIV infection, the composition and uses thereof
11/08/2005US6962803 Using corynebacterium to ferment diphtheria toxin and treat neoplasms of central nervous system; antitumor agents
11/08/2005US6962802 Growth factor homolog ZVEGF4
11/08/2005US6962801 Protein for blocking platelet adhesion
11/08/2005US6962799 Microtubule-associated proteins and tubulins
11/08/2005US6962798 Nucleotide sequences coding heart polypeptide for use in the treatment of cardiomyopathies
11/08/2005US6962796 Production of human parathyroid hormone from microorganisms
11/08/2005US6962795 Neutrophil inhibitors
11/08/2005US6962792 cyclin-dependent kinase 4 (CDK4); useful in treatment of tumours and other hyperproliferative disorders
11/08/2005US6962784 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
11/08/2005US6962718 Compositions for treating animal diseases and syndromes
11/08/2005US6962712 Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962707 Therapeutic agent comprising immunogenic, natural A beta peptide with adjuvant alum to enhance the immune response; conjugated A beta fragment with carrier T cell epitope; Alzheimer's disease
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005US6962704 Administering protein Q or a variant thereof containing modifications or substitutions of preserved amino acid residues, protein Q or variant thereof being optionally combined with complete or fragmented protein LiHsp70 and
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005US6962699 Rationally designed polysaccharide lyases derived from chondroitinase B
11/08/2005US6962698 providing expanded populations of stem cells, as well as progenitor cells, which can be used for hematopoietic cell transplantations, or generation of stem or progenitor cells suitable for genetic manipulations, which may be used for gene therapy
11/08/2005US6962697 Use of sphingomyelinase to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic compositions suitable for topical application containing same
11/08/2005US6962696 Compositions and methods for tumor-targeted delivery of effector molecules
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005CA2382599C Flushable disposable polymeric products
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/08/2005CA2149753C Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
11/07/2005CA2506492A1 Irrigation solution for use in ultrasound energy assisted surgery
11/05/2005CA2506218A1 Use of plasma proteins concentrates containing vwf with a high proportion of high molecular weight multimers
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103263A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103255A1 Formylpeptide receptor (fpr) as a target for anti-malignant glioma therapy
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103240A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)
11/03/2005WO2005103238A1 Defibrase modified by polyethylene glycol
11/03/2005WO2005103088A1 A single-domain antibody strengthening fusion protein vh-ldp-ae
11/03/2005WO2005103080A2 Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
11/03/2005WO2005103079A1 Vaccine composition comprising a class ii cmh ligand coupled with an antigen, method for the preparation and the use thereof
11/03/2005WO2005103078A1 Avian gm-csf
11/03/2005WO2005103077A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005WO2005103076A2 Erythropoietin protein variants
11/03/2005WO2005103071A1 Peptide inhibitors of metalloproteinase activity
11/03/2005WO2005103067A1 Methods and kits for stabilising, protecting and solubilising proteins
11/03/2005WO2005102395A1 Novel use of aim3 acting as a tumor suppressor
11/03/2005WO2005102382A1 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections
11/03/2005WO2005102381A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
11/03/2005WO2005102380A2 Methods of inhibiting inflammation
11/03/2005WO2005102379A2 Nucleic acid based assays for identification of fc receptor polymorphisms
11/03/2005WO2005102378A2 Modular furniture system
11/03/2005WO2005102377A1 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
11/03/2005WO2005102376A1 Preventive/remedy for diabetic nephropathy
11/03/2005WO2005102375A1 Corneal neuritogenesis promoter containing pacap and its derivative
11/03/2005WO2005102374A2 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
11/03/2005WO2005102322A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005WO2005102293A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005WO2005102285A1 Tissue enhancement implant and method
11/03/2005WO2005084307A9 Use of lipid conjugates in the treatment of disease
11/03/2005WO2005079822A3 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds
11/03/2005WO2005079772A3 Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
11/03/2005WO2005074579A3 Peptide mixtures with immunomodulatory activity
11/03/2005WO2005063799A3 Peptide synthesis and deprotection with co-solvent
11/03/2005WO2005059123A3 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders
11/03/2005WO2005056598A3 Laminin-5 modulators and uses thereof
11/03/2005WO2005056040A3 Systems and methods related to degradation of uremic toxins
11/03/2005WO2005049099A3 Fibres embedded in a glassy protein
11/03/2005WO2005046454A3 Methods of using gelsolin to treat or prevent bacterial sepsis
11/03/2005WO2005045037A3 RNA INTERFERENCE MEDIATED INHIBITION OF 5-ALPHA REDUCTASE AND ANDROGEN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2005WO2005041631A3 Endotheliase-1 ligands
11/03/2005WO2005039645A3 Sp1 and sp3 targeted cancer therapies and therapeutics
11/03/2005WO2005038000A3 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
11/03/2005WO2005037214A3 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 3163